All Equities articles – Page 34
-
White papers
China outlook – Some unconventional thoughts
While there appears to be a large degree of market consensus on China’s GDP growth in 2022, there is less clarity on the three to five-year outlook. A raft of issues could slow growth momentum in 2022.
-
White papers
SDG Engagement Equity commentary: National Instruments
The SDG Engagement Equity Fund focuses on attractive companies with the potential – through engagement aligned with the Sustainable Development Goals (SDGs) – to generate outcomes that benefit people, the planet and investors.
-
White papers
SDG Engagement Equity commentary: Eagle Materials
The SDG Engagement Equity Fund focuses on attractive companies with the potential – through engagement aligned with the Sustainable Development Goals (SDGs) – to generate outcomes that benefit people, the planet and investors. Here we demonstrate how we are engaging with current holding Eagle Materials to create positive impacts on the environment.
-
White papers
After a difficult year, biotechnology holds the potential to reawaken in 2022
Franklin Equity Group’s Wendy Lam addresses recent biotech industry headwinds and the case for stronger equity results in 2022.
-
White papers
2022: A Year of Major Inflection Points
These five big transitions are likely to make 2022 a choppy and challenging year for equity investors—and the end of the coronavirus pandemic doesn’t even make the cut.
-
White papers
CLOs: A Safe Haven Amid Rising Rates?
CLOs offer a number of potential benefits in a rising rate environment, with BB and equity tranches offering particular value.
-
White papers
What is driving the sudden spate of telecoms buyouts and is it good for investors?
The European telecommunication industry has been the problem child of the equity market for some years, writes Joe Howes, Credit Analyst
-
White papers
Hawkish Fed Makes Markets Rethink Pricing
Markets boosted and pulled forward rate hike expectations following the FOMC’s hawkish shift, with three hikes priced for 2022. While our baseline outlook sees the Fed tightening this year, we believe it will remain accommodative, so growth doesn’t slow too much and derail the recovery.
-
White papers
US Stocks: Enduring Advantages for Testing Times
After three supercharged years for US equities, many investors wonder whether the market still has fuel for 2022. While higher valuations warrant caution, we believe a carefully chosen allocation can capture advantages inherent to the US market that underpin solid long-term return potential.
-
White papers
Chinese equities: Conviction amid change
Franklin Templeton Emerging Market Equity’s Micheal Lai expects quality companies in China to deliver growth across market cycles.
-
White papers
You asked, we answer - January 2022
A number of scheduled country-level elections will carry moderate uncertainty. However, while they could bring new faces, they are unlikely to result in abrupt changes from the current generally pro-European and market-friendly stance of large EU countries’ governments.
-
White papers
China’s growth cycle is turning
Senior market strategist APAC Chi Lo discusses how Beijing has shifted to a pro-growth policy and away from painful economic restructuring as growth momentum slows to levels below what is tolerable to Chinese policymakers.
-
Podcast
Macroeconomics and markets in 2022 – Rebalancing supply and demand
What can investors expect after a year marked by new phases of the pandemic and given the prospect of another year that could see further outbreaks, renewed restrictions on mobility and activity? What is the macroeconomic outlook for 2022? What can we expect from the markets?
-
White papers
Where are the opportunities in private equity?
It’s been a bumper period of performance - across the card - for private equity. Our experts explain why returns been so strong and offer their views on what comes next.
-
White papers
Select emerging markets set to stand out amid the global tightening cycle in 2022
Templeton Global Macro: the promise of a full recovery in 2021 feels like unfinished business. We expect to get closer to that realized recovery in 2022.
-
White papers
Shooting the rapids in 2022 – Our investment outlook in an infographic
What can investors expect after a year marked by new phases of the pandemic and given the prospect of another year that could see further outbreaks, renewed restrictions on mobility and activity, and a slowing economic recovery?
-
White papers
The Beginning of the Beginning: Byte, Atom, Gene
Franklin Equity Group is excited about the future; whatever the new year brings, we anticipate enhancements to our ways of life.
-
Video
Let’s Get Physical: Unlocking Real Assets for Liability-Driven Investors
While many financial concepts and securities can sometimes feel abstract, real assets are refreshingly tangible. As investments that enable the everyday functioning of society, real assets have intrinsic value and typically generate stable, predictable cash flows that can act as an inflation-hedge. These qualities mean real assets are increasingly important sources of portfolio diversification.
-
White papers
Outlook 2022 - Bye-bye beta
Despite a fifth coronavirus wave rising as we enter the third year of the pandemic, there are reasons to be optimistic for the economic recovery, explain the Generali Insurance Asset Management Macro Research Team. In fact, a global 60-40 portfolio would have risen nearly 40% since the lows of March 2020.
-
Podcast
2022 Outlook Series: Investing Through Climate Risk
Climate change is already having material impacts on public and private asset classes across developed and emerging markets.